• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用基于主体的模型评估针对性的新冠疫苗接种策略。

Evaluating targeted COVID-19 vaccination strategies with agent-based modeling.

作者信息

Hladish Thomas J, Pillai Alexander N, Pearson Carl A B, Toh Kok Ben, Tamayo Andrea, Stoltzfus Arlin, Longini Ira M

机构信息

Department of Biology, University of Florida, Gainesville, Florida, USA.

Emerging Pathogens Institute, University of Florida, Gainesville, Florida, USA.

出版信息

medRxiv. 2023 Mar 10:2023.03.09.23285319. doi: 10.1101/2023.03.09.23285319.

DOI:10.1101/2023.03.09.23285319
PMID:36945423
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10029084/
Abstract

We evaluate approaches to vaccine distribution using an agent-based model of human activity and COVID-19 transmission calibrated to detailed trends in cases, hospitalizations, deaths, seroprevalence, and vaccine breakthrough infections in Florida, USA. We compare the incremental effectiveness for four different distribution strategies at four different levels of vaccine availability, reflecting different income settings' historical COVID-19 vaccine distribution. Our analysis indicates that the best strategy to reduce severe outcomes is to actively target high disease-risk individuals. This was true in every scenario, although the advantage was greatest for the middle-income-country availability assumptions, and relatively modest compared to a simple mass vaccination approach for rapid, high levels of vaccine availability. Ring vaccination, while generally the most effective strategy for reducing infections, ultimately proved least effective at preventing deaths. We also consider using age group as a practical, surrogate measure for actual disease-risk targeting; this approach still outperforms both simple mass distribution and ring vaccination. We also find that the magnitude of strategy effectiveness depends on when assessment occurs (., after delta vs. after omicron variants). However, these differences in absolute benefit for the strategies do not change the ranking of their performance at preventing severe outcomes across vaccine availability assumptions.

摘要

我们使用一种基于主体的人类活动和新冠病毒传播模型来评估疫苗分配方法,该模型已根据美国佛罗里达州病例、住院、死亡、血清流行率和疫苗突破性感染的详细趋势进行了校准。我们比较了在四种不同疫苗可及水平下四种不同分配策略的增量效果,这四种水平反映了不同收入环境下新冠疫苗的历史分配情况。我们的分析表明,降低严重后果的最佳策略是积极针对高疾病风险个体。在每种情况下都是如此,尽管在中等收入国家的疫苗可及性假设下优势最大,并且与快速实现高疫苗可及性的简单大规模接种方法相比相对较小。环形接种虽然通常是减少感染最有效的策略,但最终证明在预防死亡方面效果最差。我们还考虑将年龄组作为针对实际疾病风险的一种实用替代指标;这种方法仍然优于简单的大规模分配和环形接种。我们还发现,策略有效性的程度取决于评估时间(例如,在德尔塔毒株出现后与奥密克戎毒株出现后)。然而,这些策略在绝对收益上的差异并没有改变它们在不同疫苗可及性假设下预防严重后果的性能排名。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/4288529975dd/nihpp-2023.03.09.23285319v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/85490fedf023/nihpp-2023.03.09.23285319v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/6868e5ba05f1/nihpp-2023.03.09.23285319v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/a347f5e0f8bd/nihpp-2023.03.09.23285319v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/7334f5deaaef/nihpp-2023.03.09.23285319v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/2c7b313ca68f/nihpp-2023.03.09.23285319v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/a28c34061a09/nihpp-2023.03.09.23285319v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/4288529975dd/nihpp-2023.03.09.23285319v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/85490fedf023/nihpp-2023.03.09.23285319v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/6868e5ba05f1/nihpp-2023.03.09.23285319v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/a347f5e0f8bd/nihpp-2023.03.09.23285319v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/7334f5deaaef/nihpp-2023.03.09.23285319v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/2c7b313ca68f/nihpp-2023.03.09.23285319v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/a28c34061a09/nihpp-2023.03.09.23285319v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffa0/10029084/4288529975dd/nihpp-2023.03.09.23285319v1-f0007.jpg

相似文献

1
Evaluating targeted COVID-19 vaccination strategies with agent-based modeling.使用基于主体的模型评估针对性的新冠疫苗接种策略。
medRxiv. 2023 Mar 10:2023.03.09.23285319. doi: 10.1101/2023.03.09.23285319.
2
Evaluating targeted COVID-19 vaccination strategies with agent-based modeling.基于代理的建模评估靶向 COVID-19 疫苗接种策略。
PLoS Comput Biol. 2024 May 31;20(5):e1012128. doi: 10.1371/journal.pcbi.1012128. eCollection 2024 May.
3
Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions With Infections, Hospitalizations, and Mortality.模拟 COVID-19 疫苗接种和非药物干预措施与感染、住院和死亡的关联。
JAMA Netw Open. 2021 Jun 1;4(6):e2110782. doi: 10.1001/jamanetworkopen.2021.10782.
4
An agent-based model to assess large-scale COVID-19 vaccination campaigns for the Italian territory: The case study of Lombardy region.基于代理的模型评估意大利大规模 COVID-19 疫苗接种活动:伦巴第大区案例研究。
Comput Methods Programs Biomed. 2022 Sep;224:107029. doi: 10.1016/j.cmpb.2022.107029. Epub 2022 Jul 16.
5
The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.在英国和美国,针对成年人的 COVID-19 疫苗副作用风险的描述和沟通对疫苗接种意愿的影响:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Sep 6;22(1):592. doi: 10.1186/s13063-021-05484-2.
6
Decrease in COVID-19 adverse outcomes in adults during the Delta and Omicron SARS-CoV-2 waves, after vaccination in Mexico.墨西哥接种疫苗后,德尔塔和奥密克戎 SARS-CoV-2 波期间成年人 COVID-19 不良结局减少。
Front Public Health. 2022 Sep 13;10:1010256. doi: 10.3389/fpubh.2022.1010256. eCollection 2022.
7
Effectiveness of BNT162b2 and CoronaVac COVID-19 vaccination against asymptomatic and symptomatic infection of SARS-CoV-2 omicron BA.2 in Hong Kong: a prospective cohort study.BNT162b2 和 CoronaVac 新冠疫苗对奥密克戎 BA.2 亚谱系引起的 SARS-CoV-2 无症状和有症状感染的有效性:一项前瞻性队列研究。
Lancet Infect Dis. 2023 Apr;23(4):421-434. doi: 10.1016/S1473-3099(22)00732-0. Epub 2022 Dec 12.
8
Tailoring COVID-19 Vaccination Strategies in High-Seroprevalence Settings: Insights from Ethiopia.在高血清流行率地区制定新冠疫苗接种策略:来自埃塞俄比亚的见解
Vaccines (Basel). 2024 Jul 5;12(7):745. doi: 10.3390/vaccines12070745.
9
SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.接种加强针后感染 SARS-CoV-2:一项前瞻性、基于社区的病例对照研究中的疾病和症状特征。
J Infect. 2023 Dec;87(6):506-515. doi: 10.1016/j.jinf.2023.08.009. Epub 2023 Sep 28.
10
Tuberculosis结核病

本文引用的文献

1
Why hybrid immunity is so triggering.为什么混合免疫如此引发反应。
Lancet Infect Dis. 2022 Dec;22(12):1649. doi: 10.1016/S1473-3099(22)00746-0. Epub 2022 Nov 10.
2
Ring vaccination of COVID-19 vaccines in medium- and high-risk areas of countries with low incidence of SARS-CoV-2 infection.在新冠病毒感染低发国家的中高风险地区进行新冠疫苗的环状接种。
Clin Transl Med. 2021 Feb;11(2):e331. doi: 10.1002/ctm2.331.
3
Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.基于模型的 COVID-19 疫苗优先接种策略,按年龄和血清学状态分层。
Science. 2021 Feb 26;371(6532):916-921. doi: 10.1126/science.abe6959. Epub 2021 Jan 21.
4
Contact Tracing during Coronavirus Disease Outbreak, South Korea, 2020.2020 年韩国冠状病毒病疫情期间的接触者追踪。
Emerg Infect Dis. 2020 Oct;26(10):2465-2468. doi: 10.3201/eid2610.201315. Epub 2020 Jul 16.
5
Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020.对接触确诊 COVID-19 患者的人员进行主动监测-美国,2020 年 1 月至 2 月。
MMWR Morb Mortal Wkly Rep. 2020 Mar 6;69(9):245-246. doi: 10.15585/mmwr.mm6909e1.
6
Designing effective control of dengue with combined interventions.设计综合干预措施有效控制登革热。
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):3319-3325. doi: 10.1073/pnas.1903496117. Epub 2020 Jan 23.
7
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.季节性流感疫苗预防和控制:免疫实践咨询委员会的建议 - 美国,2019-20 流感季。
MMWR Recomm Rep. 2019 Aug 23;68(3):1-21. doi: 10.15585/mmwr.rr6803a1.
8
MERS-coronavirus: From discovery to intervention.中东呼吸综合征冠状病毒:从发现到干预
One Health. 2016 Dec 23;3:11-16. doi: 10.1016/j.onehlt.2016.12.001. eCollection 2017 Jun.
9
Vaccination against 2009 pandemic H1N1 in a population dynamical model of Vancouver, Canada: timing is everything.在加拿大温哥华的人口动力学模型中对 2009 年大流行 H1N1 的疫苗接种:时机就是一切。
BMC Public Health. 2011 Dec 14;11:932. doi: 10.1186/1471-2458-11-932.
10
Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.适应疫苗接种策略以减轻大流行性流感:以墨西哥为例的研究。
PLoS One. 2009 Dec 3;4(12):e8164. doi: 10.1371/journal.pone.0008164.